Aagaard, Niels Kristian; Malago, Massimo; De Gottardi, Andrea; Thomas, Michael; Sauter, Gerd; Engelmann, Cornelius; Aranovich, David; Cohen, Michal; Thévenot, Thierry; Ehmann, Thomas; Capel, Jeroen; Angeli, Paolo; Jalan, Rajiv; Stirnimann, Guido (2022). Consensus care recommendations for alfapump® in cirrhotic patients with refractory or recurrent ascites. BMC gastroenterology, 22(1), p. 111. BioMed Central 10.1186/s12876-022-02173-5
|
Text
s12876-022-02173-5.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (958kB) | Preview |
BACKGROUND
The alfapump® is an implantable class III medical device that pumps ascitic fluid from the peritoneal space to the urinary bladder from where it is excreted. The pump reduces or abrogates the need for repeated paracentesis in patients with recurrent or refractory ascites.
AIMS
To improve outcomes for alfapump® implantation and pre- and post-implant patient management in both clinical trial and real-world settings by development of consensus recommendations.
METHODS
The alfapump® working group consisting of hepatologists and surgeons with extensive experience in implantation of the alfapump® and patient management met on two occasions: (1) to determine the key areas where recommendations should be made; and (2) to discuss the experiences of the working group within those areas and formulate draft statements. Developed statements were submitted to the group and consensus sought on relevance and wording through a collaborative iterative approach in order to consolidate the recommendations into consensus statements. Only recommendations agreed upon unanimously were included.
RESULTS
Twenty-three consensus recommendations were developed in the areas of pre-implantation procedure, (three statements), surgical implant procedure (11 statements), immediate post-implant care (three statements) and long-term management (six statements).
CONCLUSIONS
The consensus statements are a valuable reference resource for physicians managing patients with the alfapump® and for those considering management strategies for patients with refractory ascites.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology |
UniBE Contributor: |
Stirnimann, Guido |
ISSN: |
1471-230X |
Publisher: |
BioMed Central |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
11 Mar 2022 10:22 |
Last Modified: |
05 Dec 2022 16:14 |
Publisher DOI: |
10.1186/s12876-022-02173-5 |
PubMed ID: |
35260086 |
Uncontrolled Keywords: |
Alfapump Ascites Cirrhosis Implantation Long-term antibiotics Medical device Paracentesis Patient management Refractory ascites TIPSS |
BORIS DOI: |
10.48350/167243 |
URI: |
https://boris.unibe.ch/id/eprint/167243 |
Actions (login required)
 |
Edit item |